CREB1 and type 2 diabetes mellitus: Increased BDNF concentrations in persons with Type II Diabetes illicit increased metabolic effects such as the upregulations of neurotrophin receptor tyrosine kinase (TrkB) and cAMP-response element binding protein (CREB) pathways.